CD14 and COVID-19: Concurrently, current research in COVID-19 has highlighted the overactivation of CD14+ monocytes and the emergence of novel monocytic subsets including myeloid-derived suppressor cell (MDSC)-like suppressive monocytes within COVID-19 patients (5, 12, 21, 28, 29).